Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMountview Est. Regulatory News (MTVW)

Share Price Information for Mountview Est. (MTVW)

Share Price is delayed by 15 minutes
Get Live Data
8,900.00    -100.00 (-1.11%)
Bid:
8,800.00
Ask:
9,000.00
Spread: 200.00 (2.273%)
Market Cap: £350.91m
MTVW Live PriceLast checked at - London Stock Exchange

Intraday Mountview Est. Share Chart

Directorate Change

19 Nov 2024 09:59

RNS Number : 8039M
Mountview Estates PLC
19 November 2024
 

19 November 2024

MOUNTVIEW ESTATES P.L.C.

 

Mountview Estates P.L.C.

("Mountview" or "the Company")

 

Directorate Change

Mountview Estates P.L.C. announces that Tracey Hartley MSc MBA MRICS FTPI has been appointed as an independent Non-Executive Director of the Company, with effect from 1 January 2025. Tracey will join the Audit and Risk Committee, Remuneration Committee and Nomination Committee on appointment.

Tracey has over 25 years of expertise in residential property investment, property, and asset management across Estate, Block, and Build to Rent (BTR) sectors. She has also established a strong track record in senior leadership, strategy, and operations.

Her career includes a decade in Operations and Fund Management roles at Grainger, and she has served as the Head of Residential at The Howard de Walden Estate, JLL - The Crown Estate, and Chief Operating Officer at Cortland Europe before joining CompassRock International as Senior Director - Operations in June 2024.

Tracey has a keen focus on governance, risk, and compliance, ensuring best practices are followed across all levels of operations. Her industry-shaping roles include participating in the Government's Private Rented Sector (PRS) Taskforce, serving as the current Chair of the British Property Federation (BPF) Residential Management Committee, being a member of the BPF Living Sectors Board and the RICS UK & Ireland World Regional Board.

Duncan Sinclair, Chief Executive Officer, commented:

"Tracey brings a wealth of relevant experience to the board. We welcome her to Mountview and look forward to working with her."

 

There are no further items requiring disclosure under the Financial Conduct Authority's UK Listing Rule 6.4.8R regarding this appointment.

 

~Ends~

 

For further information on the Company, visit: www.mountviewplc.co.uk 

 

SPARK Advisory Partners Limited (Financial Adviser)

www.sparkadvisorypartners.com 

Mark Brady - 020 3368 3550

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGCBDBRUBDGSC
Date   Source Headline
14th Mar 20242:04 pmRNSDirector/PDMR Shareholding
9th Feb 20247:00 amRNSUpdate on 2023 Annual General Meeting outcome
8th Feb 20245:45 pmRNSHolding in Company
15th Jan 20247:00 amRNSAppointment of Auditor
23rd Nov 20237:00 amRNSUnaudited Interim Results for 6m ended 30 Sep 2023
20th Nov 202312:13 pmRNSResult of General Meeting
25th Oct 202312:00 pmRNSNotice of General Meeting
2nd Oct 20235:05 pmRNSResignation of Auditor
9th Aug 20231:26 pmRNSResult of AGM
28th Jul 202311:36 amRNSPublication of 2023 Annual Report and Accounts
28th Jul 20237:00 amRNSPublication of 2023 Annual Report and Accounts
7th Jul 20237:00 amRNSAnnual Financial Report and Notice of AGM
30th Jun 20232:34 pmRNSTR-1: Notification of major holdings
28th Jun 202311:43 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSPreliminary Results: year ended 31 March 2023
23rd May 20239:39 amRNSUpdate on General Meeting voting outcome
23rd Mar 20234:20 pmRNSDirector/PDMR Shareholding
2nd Feb 20237:00 amRNSUpdate on 2022 Annual General Meeting outcome
19th Jan 202312:48 pmRNSTR-1: Notification of major holdings
6th Dec 20224:40 pmRNSSecond Price Monitoring Extn
6th Dec 20224:35 pmRNSPrice Monitoring Extension
24th Nov 20227:00 amRNSUnaudited Interim Results; 6m to 30 Sept 2022
21st Nov 202211:29 amRNSResult of General Meeting
14th Nov 20228:58 amRNSAnnouncement re the Sinclair Family Concert Party
26th Oct 202211:48 amRNSNotice of General Meeting
15th Sep 20225:59 pmRNSTR-1: Notification of major holdings
10th Aug 20221:16 pmRNSResult of AGM
27th Jul 20225:08 pmRNSDirector/PDMR Shareholding
11th Jul 20226:18 pmRNSAnnual Financial Report & Notice of AGM
16th Jun 20227:00 amRNSPreliminary Results: year ended 31 March 2022
23rd May 20227:00 amRNSUpdate on General Meeting voting outcome
23rd Mar 202211:38 amRNSDirector/PDMR Shareholding
11th Feb 20227:00 amRNSUpdate on 2021 Annual General Meeting outcome
25th Nov 20218:19 amRNSUnaudited Interim Results for 6m ended 30 Sep 2021
22nd Nov 20211:08 pmRNSResult of General Meeting
27th Oct 20217:00 amRNSNotice of General Meeting
11th Aug 20213:05 pmRNSResult of AGM
3rd Aug 20219:09 amRNSAGM arrangements update
28th Jul 202112:05 pmRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSPublication of 2021 Annual Report & Notice of AGM
17th Jun 20217:00 amRNSPreliminary Results - year ended 31 March 2021
24th May 20217:00 amRNSUpdate on General Meeting voting outcome
29th Mar 20214:51 pmRNSDirector/PDMR Shareholding
16th Mar 202112:49 pmRNSDirector/PDMR Shareholding
12th Feb 20217:00 amRNSUpdate on 2020 Annual General Meeting outcome
26th Nov 202010:45 amRNSHalf-year Report
23rd Nov 202012:22 pmRNSResult of General Meeting
2nd Nov 20207:00 amRNSTR-1: Notification of Major Holdings
30th Oct 20205:04 pmRNSNotice of General Meeting
12th Aug 20203:37 pmRNSResult of Annual General Meeting - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.